{
  "query": "failure induce clinical remission",
  "studies": {
    "protocolSection": [
      {
        "identificationModule": {
          "nctId": "NCT07060001",
          "briefTitle": "Efficacy of Hypomethylating Agents vs. Intensive Chemotherapy in Acute Myeloid Leukemia Using 5hmC as a Blood-Based Minimal Residual Disease Marker"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-07",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2029-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Acute Myeloid Leukemia (AML)", "Acute Myeloid Leukaemia (AML)"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 112,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01190930",
          "briefTitle": "Risk-Adapted Chemotherapy in Treating Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia or Localized B-Lineage Lymphoblastic Lymphoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2010-08-09",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-03-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Acute Lymphoblastic Leukemia", "Adult B Lymphoblastic Lymphoma", "Ann Arbor Stage I B Lymphoblastic Lymphoma", "Ann Arbor Stage II B Lymphoblastic Lymphoma", "Childhood B Acute Lymphoblastic Leukemia", "Childhood B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1", "Childhood B Lymphoblastic Lymphoma", "Down Syndrome", "Hypodiploid B Acute Lymphoblastic Leukemia", "Philadelphia Chromosome Positive"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 9350,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "1 Year",
          "maximumAge": "30 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05539625",
          "briefTitle": "Mini-MARVEL - Mitochondrial Antioxidant Therapy in Ulcerative Colitis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-12",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2026-10-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Ulcerative Colitis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 120,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "6 Years",
          "maximumAge": "17 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05029141",
          "briefTitle": "New Double Epigenetic Regimen in the Treatment of Relapsed or Refractory Acute Myeloid Leukemia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-09-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-08-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Acute Myeloid Leukemia", "Refractory Acute Leukemia", "Relapsed Adult AML"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 21,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "69 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06533748",
          "briefTitle": "Therapy for Newly Diagnosed Patients With B-Cell Precursor Acute Lymphoblastic Leukemia and Lymphoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-01-23",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2034-05",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Acute Lymphoblastic Leukemia", "Lymphoblastic Lymphoma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 128,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "1 Year",
          "maximumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04175587",
          "briefTitle": "Randomized,International Multi-center Clinical Trial of RIF Plus RA for Non-high-risk APL"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-12-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2023-08-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Acute Promyelocytic Leukaemia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 109,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00737789",
          "briefTitle": "Mesalazine 4g Once Daily Versus 4g in Two Divided Doses in Active Ulcerative Colitis."
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2008-11"
          },
          "completionDateStruct": {
            "date": "2010-06",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Ulcerative Colitis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 206,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02454647",
          "briefTitle": "Induction Chemotherapy, Chemoradiotherapy and Surgery in Locally Advanced Gastric Cancer Patients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-09"
          },
          "completionDateStruct": {
            "date": "2015-03",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Gastric Cancer", "Adenocarcinoma", "Effects of Chemotherapy", "Surgery", "Gastrointestinal Neoplasms"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 46,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04493164",
          "briefTitle": "CPX-351 and Ivosidenib for the Treatment of IDH1 Mutated Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-12-30",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-06-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Acute Myeloid Leukemia With Gene Mutations", "Myelodysplastic Syndrome", "Myeloproliferative Neoplasm", "Recurrent Acute Myeloid Leukemia", "Refractory Acute Myeloid Leukemia"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 30,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04476576",
          "briefTitle": "Aerobic Exercise is Cardio-protective in Hemato-oncological Disease and New-onset Chemotherapy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-03-02",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-06-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Cardiotoxicity", "Systolic Dysfunction", "Exercise, Aerobic"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 38,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01452646",
          "briefTitle": "Risk-adapted, MRD-directed Therapy for Young Adults With Newly Diagnosed Acute Myeloid Leukemia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-07-10",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Acute Myeloid Leukemia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 515,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "60 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01550224",
          "briefTitle": "Temozolomide Plus Vorinostat in Relapse/Refractory Acute Myeloid Leukemia (AML)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-05-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2014-11-17",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Acute Myeloid Leukemia With 11q23-abnormality in Relapse"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 23,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01047735",
          "briefTitle": "The TRIABETES - ARMMS-T2D Study: A Randomized Trial to Compare Surgical and Medical Treatments for Type 2 Diabetes"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2009-09-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-07-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Type 2 Diabetes Mellitus", "Obesity"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 69,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "25 Years",
          "maximumAge": "55 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02014558",
          "briefTitle": "Dose Escalation Study Investigating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics of ASP2215 in Patients With Relapsed or Refractory Acute Myeloid Leukemia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-10-09",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-03-07",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Acute Myeloid Leukemia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 265,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05623722",
          "briefTitle": "Erector Spinae Plane Block Improves Organ Dysfunction in Septic Patients With Acute Gastrointestinal Injury"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-12-29",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Sepsis", "Acute Gastrointestinal Injury", "Organ Dysfunction Syndrome"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 116,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06917911",
          "briefTitle": "Testing the Addition of Venetoclax or Gemtuzumab Ozogamicin (GO) to Usual Treatment Regimen (Cytarabine and Daunorubicin, \"7+3\") for Core Binding Factor Acute Myeloid Leukemia (CBF-AML) to Improve Response (A MyeloMATCH Treatment Trial)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2026-02-18",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2027-11-25",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Core Binding Factor Acute Myeloid Leukemia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 162,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "59 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05387616",
          "briefTitle": "A Prospective Multicenter Phase 2 Study of the Chemotherapy-Free Combination of the Intravenous Phosphatidylinositol-3-Kinase (PI3K) Inhibitor Copanlisib in Combination With Obinutuzumab in Patients With Previously Untreated Follicular Lymphoma (FL) and a High Tumor Burden"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-10-19",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-05-19",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Follicular Lymphoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 98,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07037732",
          "briefTitle": "Circulating B-cell, Drug and Anti-drug Antibodies Monitoring in Patients Treated With Rituximab for Autoimmune Disorders"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-06-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2030-06-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Autoimmune Cytopenia", "Connective Tissue Disorder", "Systemic Vasculitis"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 50,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02105116",
          "briefTitle": "AML Therapy With Irradiated Allogeneic Cells"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-02"
          },
          "completionDateStruct": {
            "date": "2015-12-16",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Adult Acute Megakaryoblastic Leukemia (M7)", "Adult Acute Minimally Differentiated Myeloid Leukemia (M0)", "Adult Acute Monoblastic Leukemia (M5a)", "Adult Acute Monocytic Leukemia (M5b)", "Adult Acute Myeloblastic Leukemia With Maturation (M2)", "Adult Acute Myeloblastic Leukemia Without Maturation (M1)", "Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities", "Adult Acute Myeloid Leukemia With Del(5q)", "Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)", "Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)", "Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)", "Adult Acute Myelomonocytic Leukemia (M4)", "Adult Erythroleukemia (M6a)", "Adult Pure Erythroid Leukemia (M6b)", "Recurrent Adult Acute Myeloid Leukemia", "Untreated Adult Acute Myeloid Leukemia"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 6,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03942887",
          "briefTitle": "Exploring Durable Remission With Rituximab in Antineutrophil Cytoplasmic Antibody(ANCA)-Associated Vasculitis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-05-03",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-04-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "ANCA Associated Vasculitis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 100,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05303792",
          "briefTitle": "Testing the Combination of Inotuzumab Ozogamicin and Lower Dose Chemotherapy Compared to Usual Chemotherapy for Adults With B-Cell Acute Lymphoblastic Leukemia or B-Cell Lymphoblastic Lymphoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-06-09",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-05",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["B Acute Lymphoblastic Leukemia", "B Lymphoblastic Lymphoma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 68,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "50 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01578109",
          "briefTitle": "Sorafenib Tosylate Before and After Donor Bone Marrow Transplant in Treating Patients With Acute Myeloid Leukemia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-01-13",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-03-07",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Acute Myeloid Leukemia With FLT3/ITD Mutation"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 51,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04905407",
          "briefTitle": "Tamibarotene Plus Venetoclax/Azacitidine in Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-08-26",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-08-12",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Acute Myeloid Leukemia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 66,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06182592",
          "briefTitle": "A Bridging Study of Liposomal Cytarabine-Daunorubicin in Treating Olderly Patients With Treatment-naive High-Risk (Secondary) Acute Myeloid Leukemia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2026-08",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "High-risk (Secondary) Acute Myeloid Leukemia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 120,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "60 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03280030",
          "briefTitle": "A Study of Midostaurin Efficacy and Safety in Newly Diagnosed Patients With FLT3-mutated AML"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-04-06",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-11-14",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Acute Myeloid Leukemia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 67,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00549848",
          "briefTitle": "Total Therapy Study XVI for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2007-10-29",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-03-26",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Acute Lymphoblastic Leukemia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 600,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "maximumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00317642",
          "briefTitle": "A Study of Clofarabine and Cytarabine for Older Patients With Relapsed or Refractory Acute Myelogenous Leukemia (AML)(CLASSIC I)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2006-08"
          },
          "completionDateStruct": {
            "date": "2012-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Acute Myelogenous Leukemia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 326,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "55 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05054465",
          "briefTitle": "A Phase 1b-2 Trial to Assess Venetoclax and Navitoclax Consolidation and Post-transplant Maintenance in High-risk Patients With T-ALL"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-10-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2026-08-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Acute Lymphoblastic Leukemia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 48,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05130983",
          "briefTitle": "Study of ExoFlo for the Treatment of Medically Refractory Crohn's Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-01-23",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-12-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Crohn Disease", "Inflammatory Bowel Diseases"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 3,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06228781",
          "briefTitle": "Autologous Hematopoietic Stem Cell Transplantation for Refractory Multiple Sclerosis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2026-12-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2029-01-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Multiple Sclerosis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 20,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "60 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03589729",
          "briefTitle": "Dexrazoxane Hydrochloride in Preventing Heart-Related Side Effects of Chemotherapy in Participants With Blood Cancers"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-09-19",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Acute Myeloid Leukemia", "Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive", "Blasts 10 Percent or More of Bone Marrow Nucleated Cells", "High Risk Myelodysplastic Syndrome", "Myeloid Sarcoma", "Myeloproliferative Neoplasm", "Philadelphia Chromosome Positive"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 100,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "12 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00201240",
          "briefTitle": "Acute Myeloid Leukemia T Cell Depletion to Improve Transplants in Adults With Acute Myeloid Leukemia (BMT CTN 0303)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2005-06"
          },
          "completionDateStruct": {
            "date": "2013-12",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Leukemia, Myelocytic, Acute"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 47,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06998797",
          "briefTitle": "Efficacy of Subcutaneous Infliximab in Acute Severe Ulcerative Colitis: a Multicenter Retrospective Study"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-06-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2025-10-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Ulcerative Colitis"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 50,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03701308",
          "briefTitle": "Daunorubicin and Cytarabine With or Without Uproleselan in Treating Older Adult Patients With Acute Myeloid Leukemia Receiving Intensive Induction Chemotherapy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-03-28",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-10-26",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Acute Myeloid Leukemia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 264,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "60 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01574274",
          "briefTitle": "SC-PEG Asparaginase vs. Oncaspar in Pediatric Acute Lymphoblastic Leukemia (ALL) and Lymphoblastic Lymphoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-06"
          },
          "completionDateStruct": {
            "date": "2027-07-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Acute Lymphoblastic Leukemia", "Lymphoblastic Lymphoma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 240,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "365 Days",
          "maximumAge": "21 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05523050",
          "briefTitle": "Active Surgical Intervention on Crohn's Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-09-16",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2024-05-16",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Crohn Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 100,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06233526",
          "briefTitle": "Individualized Treatment of Pediatric R/R AML Based on Transcriptomic Profile and in Vitro Drug Sensitivity Test"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-01-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Acute Myeloid Leukemia in Children"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 60,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "maximumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02521493",
          "briefTitle": "Response-Based Chemotherapy in Treating Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome in Younger Patients With Down Syndrome"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-12-23",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-06-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Acute Myeloid Leukemia", "Down Syndrome", "Myelodysplastic Syndrome", "Myeloid Leukemia Associated With Down Syndrome", "Myeloproliferative Neoplasm"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 280,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "91 Days",
          "maximumAge": "3 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01964755",
          "briefTitle": "Chemotherapy for Relapsed Epstein Barr Virus Associated Lymphoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2009-04-21",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-06-07",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Epstein Barr Virus Associated Non Hodgkin's Lymphoma", "Epstein Barr Virus Associated Hodgkin's Lymphoma", "Post-Transplant Lymphoproliferative Disease"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 6,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06156579",
          "briefTitle": "Combination Salvage Therapy With Venetoclax and Decitabine in Relapsed/Refractory AML"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-11-04",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-03",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["AML", "MDS"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 27,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05947669",
          "briefTitle": "Efficacy and Safety of Infliximab for Immune Checkpoint Inhibitor Induced Colitis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-08-22",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-09",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Colitis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 195,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03594955",
          "briefTitle": "First in Human Testing of Dose-escalation of SAR440234 in Patients With Acute Myeloid Leukemia, Acute Lymphoid Leukemia and Myelodysplastic Syndrome"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-10-24",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-02-06",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Leukaemia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 7,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "16 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00893373",
          "briefTitle": "Study Evaluating Sorafenib Added to Standard Primary Therapy in Patients With Newly Diagnosed Acute Myeloid Leukemia Less Than 60 Years of Age"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2009-03"
          },
          "completionDateStruct": {
            "date": "2014-09",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Acute Myeloid Leukemia (AML)"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 276,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "60 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06858618",
          "briefTitle": "FCN-338 in Combination With Azacitidine or Chemotherapy in Myeloid Neoplasms"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-08-16",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Safety", "Antitumor Activity", "PK Profile"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 47,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01518556",
          "briefTitle": "Safety and Efficacy Study of Idarubicin Dose Intensification to Treat Acute Myeloid Leukemia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2011-07",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-03",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Leukemia, Myeloid, Acute"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 49,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "20 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00854581",
          "briefTitle": "Zidovudine, Interferon Alfa-2b, PEG-Interferon Alfa-2b in Patients With HTLV-I Associated Adult T-Cell Leukemia/Lymphoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2007-11"
          },
          "completionDateStruct": {
            "date": "2011-11",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Lymphoma", "Precancerous/Nonmalignant Condition"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 13,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02538965",
          "briefTitle": "A Study of Lenalidomide in Pediatric Subjects With Relapsed or Refractory Acute Myeloid Leukemia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-11-19",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-01-11",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Leukemia, Myeloid"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 17,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "1 Year",
          "maximumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03669029",
          "briefTitle": "Optimization of Golimumab Treatment in Ulcerative Colitis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-10-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2019-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Colitis, Ulcerative"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 50,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00007475",
          "briefTitle": "Permeability Factor in Focal Segmental Glomerulosclerosis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2000-12"
          },
          "completionDateStruct": {
            "date": "2014-06",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Focal Segmental Glomerulosclerosis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 15,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02689869",
          "briefTitle": "Combination of PCI-32765 With Obinutuzumab in Untreated Follicular Lymphoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-04"
          },
          "completionDateStruct": {
            "date": "2022-07",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Indolent Non-Hodgkin Lymphoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 98,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05815355",
          "briefTitle": "Efficacy of Exclusive Enteral Nutrition in Adult Active Crohn's Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-07"
          },
          "completionDateStruct": {
            "date": "2015-09",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Crohn's Disease"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 48,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "60 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00374699",
          "briefTitle": "Bortezomib and CHOP in Patients With Advanced Stage Aggressive T Cell or Natural Killer (NK)/T Cell Lymphomas"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2006-04"
          },
          "completionDateStruct": {
            "date": "2009-10",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Peripheral T-Cell Lymphomas", "Non-Hodgkin Lymphoma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 55,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03474744",
          "briefTitle": "Copanlisib and Rituximab in Marginal Zone Lymphoma Patients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-12-15",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Marginal Zone Lymphoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 36,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06894459",
          "briefTitle": "A Prospective, Multicenter, Multicohort Phase II Study: Evaluating the Efficacy and Safety of Preoperative Neoadjuvant Treatment With a PD-1 Inhibitor in Combination With Chemotherapy in Locally Advanced Laryngeal and Hypopharyngeal Squamous Cell Carcinoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-05-08",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2028-12-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Head and Neck Cancers"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 180,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02768532",
          "briefTitle": "Value of Pharmacokinetic Assays in the Prediction of Induction and Maintenance Therapeutic Response in Crohn's Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-07-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-01-23",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Crohn Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 47,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03724929",
          "briefTitle": "Value of Pharmacokinetic Assays in the Prediction of Therapeutic Response in Ulcerative Colitis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-03-04",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-06-28",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Ulcerative Colitis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 67,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06410651",
          "briefTitle": "Nimotuzumab Concurrent With Chemoradiotherapy for Patients With Unresectable Esophageal Squamous Cell Carcinoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-03-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Esophageal Cancer", "Nimotuzumab", "Chemoradiotherapy", "Chemotherapy", "Immunotherapy"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 53,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03765541",
          "briefTitle": "Dexamethasone in Refractory or First Relapsed Acute Myeloid Leukemia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-01-13",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-05-31",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Relapsed or Refractory Acute Myeloid Leukemia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 73,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06874608",
          "briefTitle": "Evaluation of the Efficacy and Tolerability of an Exclusion Diet in Patients With Juvenile Idiopathic Arthritis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-12-12",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-11-15",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Juvenile Idiopathic Arthritis (JIA)"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 20,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "6 Years",
          "maximumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00742300",
          "briefTitle": "Autologous Hematopoietic Stem Cell Transplantation for Refractory Autoimmune Diseases"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "1998-01"
          },
          "completionDateStruct": {}
        },
        "conditionsModule": {
          "conditions": "Autoimmune Diseases"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {}
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "60 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06895252",
          "briefTitle": "A Study to Evaluate the Effect of Fecal Transplant and Dietary Changes on Disease Activity in Patients With Newly Diagnosed Active Ulcerative Colitis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-03-15",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-03-15",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Ulcerative Colitis (UC)"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 220,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01051063",
          "briefTitle": "Evaluation of a New Anti-cancer Immunotherapy in Adult Acute Myeloid Leukemia Patients With a Suboptimal Clinical Response to Induction Chemotherapy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2009-12-09",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2016-04-26",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Leukaemia, Myelocytic, Acute"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 17,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06084819",
          "briefTitle": "Clinical Study of Venetoclax Combined With CACAG Regimen in the Treatment of Relapsed/Refractory Acute Myeloid Leukemia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-08-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-01-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Relapsed/Refractory Acute Myeloid Leukemia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 200,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "14 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04254640",
          "briefTitle": "Efficacy and Safety of Cladribine in Combination With CAG in Newly Diagnosed Unfit Patients With AML"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-03-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2023-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Acute Myeloid Leukemia", "Elderly Patients", "Newly Diagnosed"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 34,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "90 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06985485",
          "briefTitle": "Full-Course Immunotherapy Consolidation for Unfit or Fit B-ALL Who Decline Chemotherapy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-05-17",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Acute Lymphoblastic Leukemia", "Immunotherapy", "Blinatumomab", "Inotuzumab Ozogamicin"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 26,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "15 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06827899",
          "briefTitle": "Veneclax, Chidaniline Combined With Azacitidine Followed by Decitabine + MAG Regimen in the Treatment of Elderly Untreated AML"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-07-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-06-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Acute Myeloid Leukemia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 66,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "60 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07013565",
          "briefTitle": "Chemoimmunotherapy for ALK+ Relapsed/Refractory ALCL"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-08-07",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2030-07-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Anaplastic Large Cell Lymphoma, ALK-Positive"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 20,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "1 Year",
          "maximumAge": "39 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01224171",
          "briefTitle": "Study of Vedolizumab in Patients With Moderate to Severe Crohn's Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2010-11"
          },
          "completionDateStruct": {
            "date": "2012-04",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Crohn's Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 416,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03322865",
          "briefTitle": "Obinutuzumab in Marginal Zone Lymphoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-11-23",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Marginal Zone Lymphoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 56,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06635681",
          "briefTitle": "Efficacy of Venetoclax Combined with Intensive Chemotherapy in Different Subgroups of AML"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-09-29",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-10-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "AML (Acute Myelogenous Leukemia)"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 1200,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "14 Years",
          "maximumAge": "60 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00651261",
          "briefTitle": "Daunorubicin, Cytarabine, and Midostaurin in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2008-04",
            "type": "ACTUAL"
          },
          "completionDateStruct": {}
        },
        "conditionsModule": {
          "conditions": "Leukemia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 717,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "59 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00546897",
          "briefTitle": "Lenalidomide in Older Patients With Acute Myeloid Leukemia Without Chromosome 5q Abnormalities"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2007-02"
          },
          "completionDateStruct": {
            "date": "2012-03",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Leukemia, Myeloid, Acute"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 48,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "60 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05401097",
          "briefTitle": "IDH Targeted/Non- Targeted vs Non-targeted/IDH-targeted Approaches in the Treatment of Newly Diagnosed IDH Mutated AML Patients Not Candidates for Intensive Induction Therapy (I- DATA Study)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-09-13",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2029-06-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Acute Myeloid Leukemia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 125,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03518086",
          "briefTitle": "An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-06-18",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-05-15",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Ulcerative Colitis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 1281,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06643195",
          "briefTitle": "Immediate Allogeneic Hematopoietic Stem Cell Transplantation Versus Re-treatment for Patients With High-Risk Acute Myeloid Leukemia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-01-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2027-09-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "AML"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 358,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04147533",
          "briefTitle": "Efficacy and Safety of TKIs' Withdrawal After a Two-step Dose Reduction in Patients with Chronic Myeloid Leukemia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-06-16",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-06",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Chronic Myeloid Leukemia, Chronic Phase", "Withdrawal;Drug"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 150,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04276740",
          "briefTitle": "MARVEL: Mitochondrial Anti-oxidant Therapy to Resolve Inflammation in Ulcerative Colitis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-05-31",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Ulcerative Colitis Flare"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 206,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04778397",
          "briefTitle": "Study of Magrolimab in Combination With Azacitidine Versus Physician's Choice of Venetoclax in Combination With Azacitidine or Intensive Chemotherapy in Patients With TP53 Mutant Acute Myeloid Leukemia That Have Not Been Treated"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-07-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-03-25",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Acute Myeloid Leukemia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 258,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06660368",
          "briefTitle": "BCL2i CLAG-M in R/R Acute Myeloid Leukemia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-11-26",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-11",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Relapsed or Refractory Acute Myeloid Leukemia (AML)"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 52,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01295476",
          "briefTitle": "Biomarker Study in Bone Marrow Samples From Patients With T-Cell Acute Lymphoblastic Leukemia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2011-04"
          },
          "completionDateStruct": {
            "date": "2013-05",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Leukemia"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 135,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "1 Year",
          "maximumAge": "30 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05860959",
          "briefTitle": "SUBLOCADE Long-term Outcomes"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-08-31",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-08-31",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Opioid Use Disorder"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 480,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00093470",
          "briefTitle": "Tipifarnib in Treating Patients With Acute Myeloid Leukemia in Remission"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2004-08-18",
            "type": "ACTUAL"
          },
          "completionDateStruct": {}
        },
        "conditionsModule": {
          "conditions": ["Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome", "Adult Acute Megakaryoblastic Leukemia", "Adult Acute Monocytic Leukemia", "Adult Acute Myeloid Leukemia in Remission", "Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11", "Adult Acute Myeloid Leukemia With Maturation", "Adult Acute Myeloid Leukemia With Minimal Differentiation", "Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11", "Adult Acute Myeloid Leukemia With t(8;21); (q22; q22.1); RUNX1-RUNX1T1", "Adult Acute Myeloid Leukemia With t(9;11)(p22.3;q23.3); MLLT3-KMT2A", "Adult Acute Myeloid Leukemia Without Maturation", "Adult Acute Myelomonocytic Leukemia", "Adult Erythroleukemia", "Adult Pure Erythroid Leukemia", "Alkylating Agent-Related Acute Myeloid Leukemia", "Myelodysplastic Syndrome With Excess Blasts", "Recurrent Adult Acute Myeloid Leukemia"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 144,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01752790",
          "briefTitle": "Efficacy and Safety of Top-down Therapy in Pediatric Crohn's Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-12"
          },
          "completionDateStruct": {
            "date": "2015-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Pediatric Crohn's Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 0,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "6 Years",
          "maximumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06777706",
          "briefTitle": "Open Label Study to Assess Safety & Efficacy of QD for Induction of Remission in Pediatric Patients with UC"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-01-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-09-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Ulcerative Colitis", "Inflammatory Bowel Diseases"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 20,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "4 Years",
          "maximumAge": "17 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04090736",
          "briefTitle": "Study to Compare Azacitidine Plus Pevonedistat Versus Azacitidine in Patients With Acute Myeloid Leukemia Not Eligible for Standard Chemotherapy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-09-24",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-06-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Leukemia, Myeloid, Acute"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 302,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06068621",
          "briefTitle": "Venetoclax Plus CACAG Regimen for Newly Diagnosed Acute Myeloid Leukemia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-03-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-08-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Acute Myeloid Leukemia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 200,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "14 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02277223",
          "briefTitle": "Curcumin in Pediatric Ulcerative Colitis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-03-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Ulcerative Colitis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 0,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "6 Years",
          "maximumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03416179",
          "briefTitle": "A Study Evaluating Intensive Chemotherapy With or Without Glasdegib or Azacitidine With or Without Glasdegib In Patients With Previously Untreated Acute Myeloid Leukemia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-04-20",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-01-17",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Leukemia, Myeloid, Acute"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 730,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02092467",
          "briefTitle": "Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-03-14",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-07-22",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Arthritis, Rheumatoid"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 4372,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "50 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02126098",
          "briefTitle": "Observation Study of Clinical Manifestation and Outcome in Chinese Patients With Pulmonary Vasculitis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-05"
          },
          "completionDateStruct": {
            "date": "2017-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["ANCA-associated Vasculitis", "Granulomatosis With Polyangiitis", "Microscopic Polyangiitis", "EosinphilicGranulomatosis With Polyangiitis"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 100,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06578247",
          "briefTitle": "Quizartinib or Placebo Plus Chemotherapy in Newly Diagnosed Patients With FLT3-ITD Negative AML"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-11-19",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2030-06-26",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Leukemia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 700,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02887287",
          "briefTitle": "Efficacy of Exclusive Enteral Nutrition in Adult Active Crohn's Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-07"
          },
          "completionDateStruct": {}
        },
        "conditionsModule": {
          "conditions": "Efficacy of Exclusive Enteral Nutrition in Adult Active Crohn's Disease With Complications or Failure of Medical Treatment"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 48,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "60 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02522169",
          "briefTitle": "TOPIT; Trough Level Optimized Pediatric Inflammatory Bowel Disease Therapy: A Multicenter Study Comparing Effectiveness of Trough Level Optimized Infliximab Maintenance Therapy With Standard Dosing Regimen of Pediatric Patients With Crohn's Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-09"
          },
          "completionDateStruct": {
            "date": "2016-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Pediatric Crohns Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 120,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "6 Years",
          "maximumAge": "17 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06128980",
          "briefTitle": "Withdrawal of Treatment for Heart Failure Patients With Recovery From Tachycardia-induced Cardiomyopathy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-01-09",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2032-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Heart Failure With Reduced Ejection Fraction", "Heart Rhythm Disorder"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 348,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01046825",
          "briefTitle": "Mature B-Cell Lymphoma And Leukemia Study III"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2010-09-09",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-08",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Mature B-Cell Lymphoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 128,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "maximumAge": "21 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05619653",
          "briefTitle": "Myocardial Protection in Patients With Post-acute Inflammatory Cardiac Involvement Due to COVID-19"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-12-12",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-03-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["COVID-19 Associated Cardiac Involvement", "Remodeling, Left Ventricle", "Remodeling, Vascular", "Left Ventricular Dysfunction", "Exercise Intolerance", "Vascular Inflammation", "Microvascular Angina", "Long COVID", "Myocarditis, Pericarditis"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 279,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07222579",
          "briefTitle": "Subcutaneous Blinatumomab for Treatment of Adult Patients With CD19-Positive Mixed Phenotype Acute Leukemia (MPAL)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2026-02",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2031-08",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["CD19 Positive", "Mixed Phenotype Acute Leukemia (MPAL)"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 78,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07028918",
          "briefTitle": "A Prospective Single-Arm StudyNCLDR"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-08-30",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2027-08-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Oral Squamous Cell Carcinoma (OSCC)"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 35,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05746689",
          "briefTitle": "Study of Sirolimus in IgG4-related Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-03-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2028-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "IgG4-related Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 20,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05577611",
          "briefTitle": "An Open, Single Center, Randomized Controlled Clinical Study of UCB (Cord Blood) in the Treatment of Newly Diagnosed Acute Myeloid Leukemia (AML)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-08-10",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-12-25",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "UCB (Cord Blood) Microtransplantation in the Treatment of Newly Diagnosed Acute Myeloid Leukemia (AML)"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 57,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL"
        }
      }
    ],
    "protocolSection.1": [
      {
        "identificationModule": {
          "nctId": "NCT02782546",
          "briefTitle": "Cytokine Induced Memory-like NK Cell Adoptive Therapy After Haploidentical Donor Hematopoietic Cell Transplantation"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-01-30",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-02-13",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Acute Myeloid Leukemia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 60,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03575325",
          "briefTitle": "Vyxeos(CPX-351) in Adults w R/R Acute Lymphoblastic Leukemia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-10-11",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-09-14",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Lymphoid Leukemia", "Acute Lymphoblastic Leukemia", "Refractory Acute Lymphoblastic Leukemia", "Relapsed Acute Lymphoblastic Leukemia"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 11,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02852694",
          "briefTitle": "Reduce Risk for Crohn's Disease Patients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-02-28",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-06-14",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Crohn's Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 192,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "6 Years",
          "maximumAge": "17 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05356169",
          "briefTitle": "Intensive Therapy Combined With Venetoclax for Adult Acute Myeloid Leukemia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-05-19",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-10-15",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Acute Myeloid Leukemia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 312,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05986903",
          "briefTitle": "Influence of HLA-DQA1*05 Genotype in Adults With Anti-TNF Treatment With Proactive Therapeutic Drug Monitoring."
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-01-11",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-01-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Drug Monitoring", "Inflammatory Bowel Diseases"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 280,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01872962",
          "briefTitle": "Induction Gemcitabine and Cisplatin in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-11"
          },
          "completionDateStruct": {
            "date": "2020-11",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Nasopharyngeal Carcinoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 480,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00541866",
          "briefTitle": "Safety and Tolerability Study of Voreloxin and Cytarabine Combination in Acute Myeloid Leukemia in Humans"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2007-10-06",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2012-02-15",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Acute Myeloid Leukemia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 110,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03922477",
          "briefTitle": "A Study Evaluating the Safety and Pharmacokinetics of Atezolizumab Administered in Combination With Hu5F9-G4 to Patients With Relapsed and/or Refractory Acute Myeloid Leukemia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-10-08",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-11-03",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Acute Myeloid Leukemia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 13,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06482684",
          "briefTitle": "CAR-T-cell Treatment for Untreated High Risk MANtle Cell Lymphoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-02-15",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2031-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Mantle Cell Lymphoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 150,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02724163",
          "briefTitle": "International Randomised Phase III Clinical Trial in Children With Acute Myeloid Leukaemia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-04",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2032-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Acute Myeloid Leukaemia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 700,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "maximumAge": "17 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06946407",
          "briefTitle": "Rituximab, Methotrexate, and Tepadina Induction Followed by Etoposide and Cytarabine Consolidation in Primary Central Nervous System Lymphoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-12-02",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2029-12-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Primary Central Nervous System Lymphoma (PCNSL)", "CNS Lymphoma Treatment"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 41,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "maximumAge": "60 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06770257",
          "briefTitle": "Daunorubicin, Cytarabine Liposomes Plus Venetoclax vs Azacitidine Plus Venetoclax in AML Patients Unfit for Intensive Chemotherapy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-12-10",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2027-06-10",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Leukemia, Myeloid, Acute"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 0,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01160354",
          "briefTitle": "Plerixafor and Clofarabine in Frontline Treatment of Elderly Patients With Acute Myelogenous Leukemia (AML)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2010-08"
          },
          "completionDateStruct": {
            "date": "2016-03",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Acute Myelogenous Leukemia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 22,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "60 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06744556",
          "briefTitle": "HAV Versus DAV/IAV Induction Regimen in Elderly Patients With AML"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-01-21",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-06-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "AML"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 60,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "60 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02668653",
          "briefTitle": "Quizartinib With Standard of Care Chemotherapy and as Continuation Therapy in Patients With Newly Diagnosed FLT3-ITD (+) Acute Myeloid Leukemia (AML)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-09-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-06-16",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Acute Myeloid Leukemia", "Leukemia"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 539,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00377637",
          "briefTitle": "A Study of Mycophenolate Mofetil (CellCept) in Management of Patients With Lupus Nephritis."
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2005-07"
          },
          "completionDateStruct": {
            "date": "2010-03",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Lupus Nephritis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 370,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "12 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06529731",
          "briefTitle": "Interferon- (IFN-) With Donor Leukocyte Infusion to Treat Relapsed Acute Myeloid Leukemia and Myelodysplastic Syndromes Post Allogeneic Hematopoietic Stem Cell Transplantation"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-09-23",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-10-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Acute Myeloid Leukemia", "Myelodysplastic Syndromes"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 45,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00013533",
          "briefTitle": "Pilot Study of Non-Myeloablative, HLA-Matched Allogeneic Stem Cell Transplantation for Pediatric Hematopoietic Malignancies"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2001-03-14"
          },
          "completionDateStruct": {
            "date": "2015-05-07",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Hodgkin Lymphoma", "Lymphocytic Leukemia", "Mixed Cell Leukemia", "Myelodysplastic Syndrome", "Non Hodgkin's Lymphoma", "CML", "ALL", "AML", "Lymphoma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 30,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "4 Years",
          "maximumAge": "20 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06861348",
          "briefTitle": "Effectiveness and Safety of InODLI for Relapsed B-ALL/LBL After Allo-HSCT"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-03-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2027-04-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Leukemia, Lymphocytic, Acute"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 23,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "14 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07014449",
          "briefTitle": "Clinical Trial of WBC100 Capsule in Relapsed/Refractory Acute Myeloid Leukemia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-11-03",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-06",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["AML (Acute Myelogenous Leukemia", "Relapsed Acute Myelogenous Leukemia", "Refractory Acute Myeloid Leukemia", "Hematologic Malignancy", "C-Myc", "Adult Acute Myeloid Leukemia"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 18,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02835729",
          "briefTitle": "A Study of Indoximod in Combination With (7+3) Chemotherapy in Patients With Newly Diagnosed Acute Myeloid Leukemia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-07"
          },
          "completionDateStruct": {
            "date": "2019-12-27",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Acute Myeloid Leukemia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 54,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03844061",
          "briefTitle": "Belimumab and Rituximab Combination Therapy for the Treatment of Diffuse Cutaneous Systemic Sclerosis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-07-29",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-06-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Systemic Sclerosis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 30,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05424562",
          "briefTitle": "A Study to Assess Change in Disease State in Adult Participants With Acute Myeloid Leukemia (AML) Ineligible for Intensive Chemotherapy Receiving Oral Venetoclax Tablets in Canada"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-09-07",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-03",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Acute Myeloid Leukemia"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 210,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02532010",
          "briefTitle": "Pacritinib Combined With Decitabine or Cytarabine in Older Patients With AML"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-06-15",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2017-10-24",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Acute Myeloid Leukemia (AML)"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 13,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04027309",
          "briefTitle": "A Study of Gilteritinib Versus Midostaurin in Combination With Induction and Consolidation Therapy Followed by One-year Maintenance in Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndromes With Excess Blasts-2 With FLT3 Mutations Eligible for Intensive Chemotherapy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-12-20",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2033-06",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Acute Myeloid Leukemia", "Myelodysplastic Syndrome With Excess Blasts-2"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 777,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00002766",
          "briefTitle": "Comparison of Two Combination Chemotherapy Regimens in Treating Adults With Previously Untreated Leukemia or Lymphoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "1996-03"
          },
          "completionDateStruct": {
            "date": "2011-09",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Leukemia", "Lymphoma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 170,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "120 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02031939",
          "briefTitle": "Randomized Controlled Study on Optimize Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Advanced Rectal Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 556,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03839771",
          "briefTitle": "A Study of Ivosidenib or Enasidenib in Combination With Induction Therapy and Consolidation Therapy, Followed by Maintenance Therapy in Patients With Newly Diagnosed Acute Myeloid Leukemia or Myedysplastic Syndrome EB2, With an IDH1 or IDH2 Mutation, Respectively, Eligible for Intensive Chemotherapy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-03-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2034-09-19",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Acute Myeloid Leukemia", "Myelodysplastic Syndrome With Excess Blasts-2"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 968,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02367326",
          "briefTitle": "Identification of Scores Associated With a Favorable Clinical Response With Thiopurines in IBD Patients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-06",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2017-08",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Inflammatory Bowel Diseases"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 400,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02407236",
          "briefTitle": "A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-07-10",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-11-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Colitis, Ulcerative", "Inflammatory Bowel Diseases"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 961,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06068868",
          "briefTitle": "Study to Evaluate Adverse Events and Movement of Intravenously (IV) Infused ABBV-787 in Adult Participants With Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-11-13",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-02-25",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Acute Myeloid Leukemia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 36,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02752035",
          "briefTitle": "A Study of ASP2215 (Gilteritinib) by Itself, ASP2215 Combined With Azacitidine or Azacitidine by Itself to Treat Adult Patients Who Have Recently Been Diagnosed With Acute Myeloid Leukemia With a FLT3 Gene Mutation and Who Cannot Receive Standard Chemotherapy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-08-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-12-18",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Acute Myeloid Leukemia (AML)", "Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) Mutation"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 183,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02723721",
          "briefTitle": "Prospective Study of Ingenol Mebutate for Non-invasive Lentigo Melanoma of the Face"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-06-15",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-01-27",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Lentigo Maligna"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 20,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00410410",
          "briefTitle": "A Study of Abatacept in Patients With Active Ulcerative Colitis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2006-12"
          },
          "completionDateStruct": {
            "date": "2009-11",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Ulcerative Colitis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 591,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06504459",
          "briefTitle": "Venetoclax in Combination With Cladribine and Cytarabine Alternating With Azacitidine Plus Venetoclax for the Treatment of Newly Diagnosed Monocytic AML and Active Signaling Mutated AML"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-01-03",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-05-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Acute Monocytic Leukemia", "Acute Myeloid Leukemia"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 40,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06906445",
          "briefTitle": "A Study to Evaluate the Effect of Fecal Transplant and Dietary Changes on Disease Activity in Patients With Ulcerative Colitis on Advanced Therapies"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-03-15",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-03-15",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Ulcerative Colitis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 220,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02763384",
          "briefTitle": "BL-8040 and Nelarabine for Relapsed or Refractory T-Acute Lymphoblastic Leukemia/ Lymphoblastic Lymphoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-12-02",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-05-22",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["T-Acute Lymphoblastic Leukemia", "Adult T Lymphoblastic Lymphoma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 12,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01074047",
          "briefTitle": "Study of Vidaza Versus Conventional Care Regimens for the Treatment of Acute Myeloid Leukemia (AML)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2010-06-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2016-07-25",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Acute Myeloid Leukemia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 488,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05520567",
          "briefTitle": "A Study of Gilteritinib, Venetoclax and Azacitidine as a Combined Treatment for People Newly Diagnosed With Acute Myeloid Leukemia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-01-31",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-07-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Acute Myeloid Leukemia (AML)", "FLT3-mutated Acute Myeloid Leukemia"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 70,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04770272",
          "briefTitle": "Study to Compare a Mono Atezolizumab Window Followed by a Atezolizumab - CTX Therapy with Atezolizumab - CTX Therapy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-03-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-10-02",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Triple-negative Breast Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 416,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02096380",
          "briefTitle": "The Value of Single-cycle TPF Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-05"
          },
          "completionDateStruct": {
            "date": "2018-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Nasopharyngeal Carcinoma"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 120,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "60 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05660746",
          "briefTitle": "Precise Infliximab Exposure and Pharmacodynamic Control"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-07-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-03-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Crohn Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 180,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "6 Years",
          "maximumAge": "22 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03512197",
          "briefTitle": "A Global Study of the Efficacy and Safety of Midostaurin + Chemotherapy in Newly Diagnosed Patients With FLT3 Mutation Negative (FLT3-MN) Acute Myeloid Leukemia (AML)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-07-20",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-02-12",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Acute Myeloid Leukemia (AML)"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 511,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00863252",
          "briefTitle": "Mycophenolate Mofetil for IgA Nephropathy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2002-03"
          },
          "completionDateStruct": {
            "date": "2009-03",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "IGA Nephropathy"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 40,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07012447",
          "briefTitle": "Venetoclax + Azacytidine for Newly Diagnosed ETP-like ALL and T-ALL With Myeloid Mutations"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-04-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-05-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Early T Acute Lymphoblastic Leukemia", "T-Acute Lymphoblastic Leukemia", "Mixed Phenotype Acute Leukemia, T/Myeloid, Nos"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 32,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "14 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01829503",
          "briefTitle": "Phase II Study of Decitabine and Cytarabine for Older Patients With Newly Diagnosed Acute Myeloid Leukemia (AML)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-02"
          },
          "completionDateStruct": {
            "date": "2017-11-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Acute Myeloid Leukemia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 44,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "60 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02993523",
          "briefTitle": "A Study of Venetoclax in Combination With Azacitidine Versus Azacitidine in Treatment Nave Participants With Acute Myeloid Leukemia Who Are Ineligible for Standard Induction Therapy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-02-02",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-01-23",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Acute Myeloid Leukemia (AML)"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 443,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04424862",
          "briefTitle": "Multitarget Therapy for Idiopathic Membranous Nephropathy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-06-09",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-02-03",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Efficacy"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 82,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05497310",
          "briefTitle": "Effectiveness and Safety of Therapy Based on Attenuated ATO Plus Low-Dose ATRA in Patients With APL"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-07-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-07-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Promyelocytic Leukemia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 15,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02303821",
          "briefTitle": "Study of Carfilzomib in Combination With Induction Chemotherapy in Children With Relapsed or Refractory Acute Lymphoblastic Leukemia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-02-16",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-06-28",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Acute Lymphoblastic Leukemia (ALL)"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 141,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "1 Month",
          "maximumAge": "21 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04268277",
          "briefTitle": "Pembrolizumab in MarginalzoneLymphoma a MULTICENTER OPEN LABEL SINGLE-ARM PHASE II STUDY"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-03-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-12-06",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Marginal Zone Lymphoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 22,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02488733",
          "briefTitle": "Early Sleeve Gastrectomy In New Onset Diabetic Obese Patients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-12"
          },
          "completionDateStruct": {
            "date": "2028-03",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Type 2 Diabetes Mellitus"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 56,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "20 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01880307",
          "briefTitle": "Infliximab Top-down in Pediatric Crohn"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-01"
          },
          "completionDateStruct": {}
        },
        "conditionsModule": {
          "conditions": "Crohn's Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 13,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "3 Years",
          "maximumAge": "17 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02101853",
          "briefTitle": "Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-12-17",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-09-16",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Recurrent B Acute Lymphoblastic Leukemia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 669,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "1 Year",
          "maximumAge": "31 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01491737",
          "briefTitle": "A Study of Pertuzumab in Combination With Trastuzumab Plus an Aromatase Inhibitor in Participants With Metastatic Human Epidermal Growth Factor Receptor 2 (HER2)-Positive and Hormone Receptor-Positive Advanced Breast Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-02-17",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-11-14",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Breast Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 258,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "FEMALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01295307",
          "briefTitle": "Clofarabine Salvage Therapy in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2011-03"
          },
          "completionDateStruct": {
            "date": "2013-12",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Acute Myeloid Leukemia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 86,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "40 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05176366",
          "briefTitle": "Study of ExoFlo for the Treatment of Medically Refractory Ulcerative Colitis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-12-19",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-12-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Ulcerative Colitis", "Inflammatory Bowel Diseases"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 4,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04617561",
          "briefTitle": "Ursodeoxycholic Acid Combined With Low Dose Glucocorticoid in the Treatment of PBC With AIH Features II"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-11-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-11-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Hepatitis, Autoimmune", "Primary Biliary Cholangitis"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 90,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06449820",
          "briefTitle": "Janus Kinase Inhibitors for the Treatment of Acute Severe Ulcerative Colitis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-04-24",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-12-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Ulcerative Colitis", "Inflammatory Bowel Diseases"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 36,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05931458",
          "briefTitle": "AppenDectomy Vs ANti TNF-a in Inducing Clinical and EnDoscopic Remission in Left-sided Ulcerative Colitis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-07-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2028-07-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Ulcerative Colitis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 94,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02545283",
          "briefTitle": "A Study of Idasanutlin With Cytarabine Versus Cytarabine Plus Placebo in Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-12-30",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-04-24",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Leukemia, Myeloid, Acute"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 447,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05062005",
          "briefTitle": "ICCRT vs. CRT for Locally Advanced Nasopharyngeal Carcinoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-09-22",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2027-08-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Locally Advanced Nasopharyngeal Carcinoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 447,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05941585",
          "briefTitle": "Mitoxantrone Hydrochloride Liposome Combined With Chemotherapy in Untreated de Novo Acute Myeloid Leukemia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-08-08",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-01-17",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Acute Myeloid Leukemia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 60,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05712278",
          "briefTitle": "A Study to Investigate Use of Off-the-shelf Natural Killer (NK) Cells (SAR445419) in Relapsed/Refractory Acute Myeloid Leukemia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-06-16",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-03-12",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Acute Myeloid Leukaemia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 7,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06298188",
          "briefTitle": "Risankizumab in Children With Crohn's Disease (RisaKids)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-10-31",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-10",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Crohn Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 90,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "6 Years",
          "maximumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07149467",
          "briefTitle": "Ustekinumab and Upadacitinib for Induction and Maintenance Therapy in Patients With Refractory Crohn's Disease: A Multicenter, Randomized, Parallel-Controlled Study"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-09-10",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2027-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Crohn&#39;s Disease Aggravated", "Crohn&#39;s Disease in Remission"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 454,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01235689",
          "briefTitle": "Efficacy and Safety of Two Treatment Algorithms in Adults With Moderate to Severe Crohn's Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2011-02-11",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2017-01-03",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Crohn's Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 252,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04307576",
          "briefTitle": "A Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-07-13",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2033-06",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Leukemia, Acute Lymphoblastic"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 6430,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "0 Years",
          "maximumAge": "45 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04848974",
          "briefTitle": "Uproleselan, Cladribine, and Low Dose Cytarabine for the Treatment of Patients With Treated Secondary Acute Myeloid Leukemia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-06-11",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-10-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Secondary Acute Myeloid Leukemia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 37,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03142113",
          "briefTitle": "Clinical Outcome After Escalation and De-escalation of Adalimumab in Real Life in Ulcerative Colitis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-11"
          },
          "completionDateStruct": {
            "date": "2017-05",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Ulcerative Colitis"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 231,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06066242",
          "briefTitle": "Optimizing Induction Chemotherapy Regimens for ND Elderly AML Patients Who Are Eligible for Intense Chemotherapy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-10-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-10-10",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Acute Myeloid Leukemia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 90,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "60 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03221166",
          "briefTitle": "Thalidomide Versus Infliximab in New Onset Crohn's Disease With Poor Prognostic Factors"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-02-27",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-07-31",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Crohn Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 9,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "6 Years",
          "maximumAge": "17 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06345287",
          "briefTitle": "Response Adaptive Radiotherapy Following Immunotherapy-based Induction for Non-HPV Related HNSCC"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-01-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Head and Neck Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 133,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02287233",
          "briefTitle": "A Study Evaluating Venetoclax in Combination With Low-Dose Cytarabine in Treatment-Nave Participants With Acute Myelogenous Leukemia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-12-31",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-08-10",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Acute Myelogenous Leukemia", "AML"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 94,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "60 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04893915",
          "briefTitle": "Cytokine-induced Memory-like NK Cells in Relapsed/Refractory AML and MDS"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-06-30",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2024-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Relapsed Acute Myeloid Leukemia", "Refractory Acute Myeloid Leukemia", "Myelodysplastic Syndromes"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 0,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04362735",
          "briefTitle": "Efficacy of Vedolizumab in Crohn's Disease Patients Naive to Biological Therapy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-08-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2021-04-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Crohn Disease"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 100,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00425438",
          "briefTitle": "A Study of CellCept (Mycophenolate Mofetil) in Patients With Lupus Nephritis."
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2007-03"
          },
          "completionDateStruct": {
            "date": "2008-04",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Lupus Nephritis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 52,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07046078",
          "briefTitle": "Combination Chemotherapy (FLAG-Ida) Followed Immediately by Reduced-Intensity Total Body Radiation Therapy and Donor Hematopoietic Cell Transplant for the Treatment of Adults Age 60 and Older With Newly Diagnosed Adverse-Risk Acute Myeloid Leukemia or Other High-Grade Myeloid Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-09-26",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2029-06-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Acute Leukemia of Ambiguous Lineage", "Acute Myeloid Leukemia", "Chronic Myelomonocytic Leukemia", "Myelodysplastic Syndrome"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 20,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07223814",
          "briefTitle": "Bleximenib in Combination With Standard Induction and Consolidation Therapy Followed by Maintenance for Treatment of Patients With Acute Myeloid Leukemia (AML)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-12",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2033-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Acute Myeloid Leukemia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 875,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05622474",
          "briefTitle": "A Multicenter Randomized Controlled Clinical Study on the Treatment of T3N1M0 High Risk Nasopharyngeal Carcinoma With or Without Induction Chemotherapy Before Concurrent Radiotherapy and Chemotherapy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-11-30",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2028-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Nasopharyngeal Carcinoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 236,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00607997",
          "briefTitle": "Study of Voreloxin (Vosaroxin) in Older Patients With Untreated Acute Myeloid Leukemia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2008-05-15",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2009-11-23",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Leukemia", "Acute Disease", "Acute Myeloid Leukemia", "Nonlymphocytic Leukemia", "Myelodysplastic Syndromes"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 113,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "60 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00708721",
          "briefTitle": "Low-dose Oral Clofarabine for the Treatment of IPSS INT-1, INT-2 or HIGH Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2008-03"
          },
          "completionDateStruct": {
            "date": "2014-11",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Cancer", "Chronic Myelomonocytic Leukemia"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 11,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02712866",
          "briefTitle": "Early Biomarkers in Circulating  47 + T Cells to Predict Response to Vedolizumab in Inflamatory Bowel Disease Patients."
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-02",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Inflammatory Bowel Disease"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 24,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05588830",
          "briefTitle": "The Efficacy and Safety of Telitacicept and Belimumab in Active Lupus Nephritis in the Real World: a Prospective Cohort Study"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-10-20",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2024-03-20",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Lupus Nephritis", "Belimumab", "Telitacicept"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 60,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03609060",
          "briefTitle": "Dexamethasone Added to Intensive Chemotherapy in Older Patients with Acute Myeloid Leukemia (AML)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-08-24",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Acute Myeloid Leukemia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 120,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "60 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05071482",
          "briefTitle": "Flumatinib Versus Imatinib Combined With Chemotherapy for de Novo Ph+ ALL"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-09-16",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-01-16",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Acute Leukemia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 39,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05952674",
          "briefTitle": "Treatment Resistant Depression and Vagus Nerve Stimulation"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-09-19",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2030-08-19",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Treatment Resistant Depression (TRD)"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 166,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00074282",
          "briefTitle": "Pentostatin, Cyclophosphamide, and Rituximab Followed By Campath-1H in Patients With Relapsed or Refractory B-Cell CLL"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2005-04-14",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-05-06",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Leukemia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 102,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02310321",
          "briefTitle": "A Study of ASP2215 in Combination With Induction and Consolidation Chemotherapy in Patients With Newly Diagnosed Acute Myeloid Leukemia."
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-02-26",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-07-09",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Acute Myeloid Leukemia", "FLT3-mutated Acute Myeloid Leukemia"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 97,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "69 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00700011",
          "briefTitle": "Clofarabine for Myelodysplastic Syndrome (MDS) Patients Who Failed Vidaza Treatment (tx)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2008-03"
          },
          "completionDateStruct": {
            "date": "2010-03",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Myelodysplastic Syndromes"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 10,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03524092",
          "briefTitle": "A Maintenance Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-10-19",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-02-17",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Ulcerative Colitis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 1177,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06742463",
          "briefTitle": "VHAG in Treating R/R T-ALL/LBL"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-12",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2028-06-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Acute T Lymphpblastic Leukemia/Lymphoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 50,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "14 Years",
          "maximumAge": "74 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05627232",
          "briefTitle": "Tazemetostat and Palbociclib With CPX-351for R/R AML"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-08-28",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Recurrent Acute Myeloid Leukemia", "Refractory Acute Myeloid Leukemia"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 24,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07268521",
          "briefTitle": "A Multicenter Phase 2 Single-arm Proof-of-concept Trial Assessing the Efficacy and Safety of Obinutuzumab in the Treatment of Non-infectious Active Cryoglobulinemia Vasculitis Refractory or Intolerant to Rituximab"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-12-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2028-09-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Cryoglobulinemic Vasculitis (CV)"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 30,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03209232",
          "briefTitle": "Infliximab Accelerated Induction in Moderate to Severe Pediatric UC"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-04-16",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-09-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Ulcerative Colitis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 10,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "6 Years",
          "maximumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04624230",
          "briefTitle": "Evaluation of Oral Tofacitinib in Children Aged 2 to 17 Years Old Suffering From Moderate to Severe Ulcerative Colitis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-08-12",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2029-05-15",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Ulcerative Colitis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 120,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "2 Years",
          "maximumAge": "17 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06782542",
          "briefTitle": "Olutasidenib, Venetoclax, and Azacitidine in IDH1 Mutated Newly Diagnosed Acute Myeloid Leukemia Patients Eligible for Intensive Induction Chemotherapy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2026-02-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2029-02-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Acute Myeloid Leukemia", "IDH1 Mutation"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 16,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01170351",
          "briefTitle": "Cyclosporine-A Versus Prednisolone for Induction of Remission in Auto-immune Hepatitis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2005-12"
          },
          "completionDateStruct": {
            "date": "2018-12",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Autoimmune Hepatitis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 55,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "16 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06724237",
          "briefTitle": "Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-12-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2033-12-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Anaplastic Large Cell Lymphoma, ALK-Negative", "Follicular Helper T-Cell Lymphoma", "Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type", "Peripheral T-Cell Lymphoma, Not Otherwise Specified"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 294,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03723343",
          "briefTitle": "GP-induced Chemotherapy Combined With IMRT and TPF-induced Chemotherapy Combined With IMRT in the Treatment of Distant Metastatic Nasopharyngeal Carcinoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-10-18",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2021-06-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Advanced Nasopharyngeal Carcinoma"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 146,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      }
    ],
    "protocolSection.2": [
      {
        "identificationModule": {
          "nctId": "NCT01532648",
          "briefTitle": "Randomized Placebo-Controlled Trial of Budesonide Multi-Matrix System (MMX) 9 Milligrams (mg) in Participants With Ulcerative Colitis Currently on a 5-Aminosalicylic Acid (5-ASA)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-01-27",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2013-10-02",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Ulcerative Colitis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 510,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02665065",
          "briefTitle": "Study of Iomab-B vs. Conventional Care in Older Subjects With Active, Relapsed or Refractory Acute Myeloid Leukemia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-06"
          },
          "completionDateStruct": {
            "date": "2026-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Acute Myeloid Leukemia", "Leukemia, Acute Myeloid", "Myeloid Leukemia, Acute", "Leukemia, Myeloid, Acute", "Acute Myelogenous Leukemia", "Leukemia, Acute Myelogenous", "Myelogenous Leukemia, Acute", "AML", "Bone Marrow Transplant"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 153,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "55 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05058404",
          "briefTitle": "Shortened vs Standard Chemotherapy Combined With Immunotherapy for the Initial Treatment of Patients With High Tumor Burden Follicular Lymphoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-12-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2030-07",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Follicular Lymphoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 605,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02517684",
          "briefTitle": "Top-down Infliximab Study in Kids With Crohn's Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-04",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Crohn's Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 100,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "3 Years",
          "maximumAge": "17 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00559585",
          "briefTitle": "Methotrexate-Inadequate Response Study"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2008-01"
          },
          "completionDateStruct": {
            "date": "2014-09",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Rheumatoid Arthritis (RA)"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 2492,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05428969",
          "briefTitle": "A Study to Assess Safety, Tolerability and Preliminary Efficacy of Bexmarilimab in Combination With Standard of Care in Patients With Hematological Malignancies"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-06-02",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-04",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Acute Myeloid Leukemia", "Chronic Myelomonocytic Leukemia", "Myelodysplastic Syndromes", "Relapsed/Refractory AML"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 181,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05009446",
          "briefTitle": "Single Arm Study of Induction Chemoradiotherapy Combined With Surgery in the Treatment of Locally Advanced SNMM"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-08-10",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2025-08-10",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Mucosal Melanoma", "Sinonasal Melanoma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 28,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02343939",
          "briefTitle": "Entospletinib Monotherapy and in Combination With Chemotherapy in Adults With Acute Myeloid Leukemia (AML)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-07-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-02-21",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Acute Myeloid Leukemia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 148,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06869265",
          "briefTitle": "Thiotepa Combined With Busulfan and Fludarabine Conditioning Regimen for Haploidentical Hematopoietic Stem Cell Transplantation in Elderly Patients With High-Risk Acute Myeloid Leukemia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-05-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2029-04-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Acute Myeloid Leukemia (AML)", "High Risk Acute Myeloid Leukemia(AML)", "Relapsed/Refractory Acute Myeloid Leukemia (AML)"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 56,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "55 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00071799",
          "briefTitle": "A Survival Study in Patients With High Risk Myelodysplastic Syndromes Comparing Azacitidine Versus Conventional Care"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2003-11-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2007-07-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Myelodysplastic Syndromes"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 358,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02927938",
          "briefTitle": "Leukemia Stem Cell Detection in Acute Myeloid Leukemia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-09"
          },
          "completionDateStruct": {
            "date": "2018-10-05",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Acute Myeloid Leukemia (AML)"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 18,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01534702",
          "briefTitle": "Dose Escalation of Clofarabine in Combination With Cytarabine and Idarubicin as Induction Therapy in High Risk AML"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-01"
          },
          "completionDateStruct": {
            "date": "2015-09",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Acute Myeloid Leukemia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 60,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04721873",
          "briefTitle": "Pharmacologic Weight Loss as Adjunct Therapy for Ulcerative Colitis in Obese Patients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-12-18",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-06-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Colitis, Ulcerative", "Obesity"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 40,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06648889",
          "briefTitle": "Isatuximab in Adult Patients With Cytologic or Molecular Relapsed/Refractory CD38 Positive T-cell Acute Lymphoblastic Leukemia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-10-22",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-08",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "T-ALL"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 40,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06773936",
          "briefTitle": "Adding Asciminib to Usual Treatment for Adults With Newly Diagnosed Philadelphia Chromosome Positive (Ph+) Acute Lymphoblastic Leukemia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-07-15",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2033-07",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia", "CD19+ Acute Leukemia"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 55,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "60 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04686006",
          "briefTitle": "Effective Iodide Therapy for Untreated Patients With Graves' Hyperthyroidism Avoiding Thionamide Drugs With Many Side Effects"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "1996-04-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {}
        },
        "conditionsModule": {
          "conditions": "Graves Disease"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 504,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "15 Years",
          "maximumAge": "90 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06744504",
          "briefTitle": "Standard-dose vs Intermediate-dose Cytarabine Induction in the Treatment of Acute Myeloid Leukemia With RUNX1-RUNX1T1"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-01-10",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2029-12-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["AML", "RUNX1-RUNX1T1 Fusion Protein Expression"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 300,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "14 Years",
          "maximumAge": "60 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06928376",
          "briefTitle": "A Multicenter RCT of \"3+7\" vs Venetoclax + CACAG in Newly Diagnosed Mid/High-Risk AML Patients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-04-18",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-10-18",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Acute Myeloid Leukemia", "First Line Therapy"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 160,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "14 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02063685",
          "briefTitle": "Study to Evaluate the Efficacy of Response-adapted Strategy in Follicular Lymphoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-07"
          },
          "completionDateStruct": {
            "date": "2021-12",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Follicular Non-Hodgkin's Lymphoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 807,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03729674",
          "briefTitle": "Comparative Effectiveness and Safety of Biosimilar and Legacy Drugs"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-11-26",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Rheumatoid Arthritis", "Ankylosing Spondylitis", "Ulcerative Colitis", "Crohn's Disease"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 800,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03620773",
          "briefTitle": "Impact of Metabolic Surgery on Pancreatic, Renal and Cardiovascular Health in Youth With Type 2 Diabetes"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-10-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-10-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Type 2 Diabetes Mellitus", "Obesity", "Bariatric Surgery Candidate", "Nephropathy", "Diabetic Kidney Disease", "Diabetes Mellitus, Type 2", "Diabetes Mellitus", "Diabetes Complications", "Weight Loss", "Diabetic Nephropathies", "Adolescent Obesity", "Pediatric Obesity"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 30,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "12 Years",
          "maximumAge": "21 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01598857",
          "briefTitle": "BIANCA-SC: A Study of the Efficacy, Safety, and Tolerability of Blisibimod in Addition to Methotrexate During Induction of Remission in Subjects With ANCA-Associated Small Vessel Vasculitis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-12"
          },
          "completionDateStruct": {}
        },
        "conditionsModule": {
          "conditions": ["Granulomatosis With Polyangiitis", "Microscopic Polyangiitis"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 0,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01661842",
          "briefTitle": "Umbilical Cord Mesenchymal Stem Cells for Patients With Autoimmune Hepatitis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2011-10"
          },
          "completionDateStruct": {
            "date": "2014-10",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Autoimmune Hepatitis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 100,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00671034",
          "briefTitle": "Calaspargase Pegol or Pegaspargase and Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2008-07-21",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-03-31",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Acute Lymphoblastic Leukemia", "Adult B Acute Lymphoblastic Leukemia", "Childhood B Acute Lymphoblastic Leukemia"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 166,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "2 Years",
          "maximumAge": "30 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06345365",
          "briefTitle": "MA+AZA Regimen for the Treatment of Newly Diagnosed Acute Myeloid Leukemia (AML)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-01-18",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Acute Myeloid Leukaemia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 154,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04385290",
          "briefTitle": "Combination of Midostaurin and Gemtuzumab Ozogamicin in First-line Standard Therapy for Acute Myeloid Leukemia (MOSAIC)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-09-04",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-04",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Acute Myeloid Leukemia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 214,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03135028",
          "briefTitle": "Entospletinib (ENTO) as Monotherapy and in Combination With Chemotherapy in Japanese Adults"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-05-19",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-02-26",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Hematologic Malignancy", "Acute Myeloid Leukemia"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 9,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06328179",
          "briefTitle": "Clinical Study Protocol for the Treatment of ND-AML and RR-AML With KMT2A Gene Abnormalities Using VHEA."
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-05-24",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-12-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Acute Myeloid Leukemia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 34,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "60 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01338740",
          "briefTitle": "Switching From Adalimumab to Infliximab"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2011-04",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2014-02-17",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Crohn's Disease"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 21,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00602667",
          "briefTitle": "Risk-Adapted Therapy for Young Children With Embryonal Brain Tumors, Choroid Plexus Carcinoma, High Grade Glioma or Ependymoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2007-12-17",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-04",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Brain and Central Nervous System Tumors"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 293,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "maximumAge": "5 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06899789",
          "briefTitle": "Long-term Follow-up of Checkpoint Inhibitors-induced Ileo-colitis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-07-29",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Immune Checkpoint Inhibitors-induced Colitis", "Advanced Melanoma Skin Cancer, Non-small Cell Lung Carcinoma, Kidney Adenocarcinoma", "Ileo-colitis", "Immune Mediated-colitis"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 250,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00476190",
          "briefTitle": "ALL Adult Consortium Trial: Adult ALL Trial"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2007-04"
          },
          "completionDateStruct": {
            "date": "2020-03",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Acute Lymphoblastic Leukemia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 112,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "50 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01165996",
          "briefTitle": "Differentiation Therapy With Decitabine in Treating Patients With Myelodysplastic Syndrome"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2010-07"
          },
          "completionDateStruct": {
            "date": "2012-08",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Chronic Myelomonocytic Leukemia", "de Novo Myelodysplastic Syndromes", "Myelodysplastic Syndromes", "Refractory Anemia", "Refractory Anemia With Excess Blasts", "Refractory Anemia With Ringed Sideroblasts", "Refractory Cytopenia With Multilineage Dysplasia", "Thrombocytopenia"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 25,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01470599",
          "briefTitle": "A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-04",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2016-07",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Crohn's Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 150,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "76 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01238211",
          "briefTitle": "Combination Chemotherapy and Dasatinib in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2010-12-14",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-03-15",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Acute Myeloid Leukemia", "Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome", "Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11", "Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11", "Adult Acute Myeloid Leukemia With t(8;21); (q22; q22.1); RUNX1-RUNX1T1", "Core Binding Factor Acute Myeloid Leukemia", "Secondary Acute Myeloid Leukemia", "Therapy-Related Acute Myeloid Leukemia"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 61,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02771457",
          "briefTitle": "Managing Infliximab Reinduction After Temporary Discontinuation of Drug"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-07"
          },
          "completionDateStruct": {
            "date": "2019-07",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Inflammatory Bowel Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 0,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04496674",
          "briefTitle": "Bispecific PSMAxCD3 Antibody CC-1 in Patients With Squamous Cell Carcinoma of the Lung"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-02-02",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-05-03",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Lung Cancer Squamous Cell"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 3,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00194818",
          "briefTitle": "Asacol Dosing Study for Active Ulcerative Colitis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2003-06"
          },
          "completionDateStruct": {
            "date": "2007-08",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Ulcerative Colitis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 7,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07303660",
          "briefTitle": "A Phase 1b Study of Lonitoclax + Azacitidine in Acute Myeloid Leukemia Patients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2026-01-10",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2027-11",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Acute Myeloid Leukemia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 66,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03533582",
          "briefTitle": "Cisplatin and Combination Chemotherapy in Treating Children and Young Adults With Hepatoblastoma or Liver Cancer After Surgery"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-05-24",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Childhood Hepatocellular Carcinoma", "Childhood Malignant Liver Neoplasm", "Fibrolamellar Carcinoma", "Hepatoblastoma", "Hepatocellular Malignant Neoplasm, Not Otherwise Specified"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 537,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "maximumAge": "30 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04227847",
          "briefTitle": "A Safety Study of SEA-CD70 in Patients With Myeloid Malignancies"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-08-07",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-07-03",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Myelodysplastic Syndrome", "Acute Myeloid Leukemia"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 178,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04517526",
          "briefTitle": "Efficacy and Safety of Platinum-based Chemotherapy + Bevacizumab + Durvalumab, and Salvage SBRT for IV Non-Small Cell Lung Cancer Patients With EGFR Mutations After Failure of First Line Osimertinib: A Multicenter, Prospective, Phase II Clinical Study"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-11-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2022-12-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Lung Cancer Stage IVEGFR-mutantTKIPD-L1SBRT"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 60,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01831232",
          "briefTitle": "Idarubicin, Cytarabine, and Pravastatin Sodium in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndromes"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-05"
          },
          "completionDateStruct": {
            "date": "2016-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Adult Acute Megakaryoblastic Leukemia (M7)", "Adult Acute Minimally Differentiated Myeloid Leukemia (M0)", "Adult Acute Monoblastic Leukemia (M5a)", "Adult Acute Monocytic Leukemia (M5b)", "Adult Acute Myeloblastic Leukemia With Maturation (M2)", "Adult Acute Myeloblastic Leukemia Without Maturation (M1)", "Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities", "Adult Acute Myeloid Leukemia With Del(5q)", "Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)", "Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)", "Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)", "Adult Acute Myelomonocytic Leukemia (M4)", "Adult Erythroleukemia (M6a)", "Adult Pure Erythroid Leukemia (M6b)", "Chronic Myelomonocytic Leukemia", "de Novo Myelodysplastic Syndromes", "Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable", "Refractory Anemia With Excess Blasts", "Untreated Adult Acute Myeloid Leukemia"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 24,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "74 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04230239",
          "briefTitle": "Clinical Trial to Assess the Efficacy and Toxicity of Induction and Consolidation With CPX-351 for Patients Aged 60 to 75 Years With Secondary or High-risk Acute Myeloid Leukemia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-12-26",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-08-11",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Newly Diagnosed Secondary or High Risk AML"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 59,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "60 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07227584",
          "briefTitle": "ALL Backbone in AYAs"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2026-04",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2035-07-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Acute Lymphoblastic Leukemia", "Philadelphia Chromosome-Negative Lymphoblastic Leukemia", "Acute Lymphoblastic Leukemia (ALL)", "Leukemia"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 67,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "51 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01580007",
          "briefTitle": "Clinical Trial of Phenylbutyrate and Vitamin D in Tuberculosis (TB)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2010-12"
          },
          "completionDateStruct": {
            "date": "2014-12",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Pulmonary Tuberculosis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 288,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "60 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07218536",
          "briefTitle": "The Burden of Atypical Hemolytic Uremic Syndrome and The Clinical Characteristics of Patients in Egyptian Hospitals A Multicenter, Observational, Retrospective Cohort Study in Egypt"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-10-13",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-09-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Atypical Hemolytic Uremic Syndrome"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 200,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02712905",
          "briefTitle": "An Open-Label, Dose-Escalation/Dose-Expansion Safety Study of INCB059872 in Subjects With Advanced Malignancies"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-05-05",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-04-14",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Solid Tumors and Hematologic Malignancy"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 116,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07132684",
          "briefTitle": "Comparison of VA and D/IA Induction Regimens in Elderly Fit Acute Myeloid Leukemia Patients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-08-31",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-08-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "AML, Adult"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 240,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "60 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05904106",
          "briefTitle": "Venetoclax Plus Azacitidine Versus Intensive Chemotherapy for Fit Patients With Newly Diagnosed NPM1 Mutated AML"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-04-07",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-09",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Acute Myeloid Leukemia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 146,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07172204",
          "briefTitle": "Alternating Regimen of VA and Low-dose CHA in the Treatment of Unfit Newly Diagnosed AML"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-09-16",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2029-07-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Intensive Chemotherapy Unfit", "Newly Diagnosed Acute Myeloid Leukemia (AML)", "Age 60"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 25,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00003863",
          "briefTitle": "Diagnostic Study of Patients With Aggressive Non-Hodgkin's Lymphoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "1999-06"
          },
          "completionDateStruct": {
            "date": "2005-05",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Lymphoma"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 391,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04778410",
          "briefTitle": "Study of Magrolimab Combinations in Participants With Myeloid Malignancies"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-06-28",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-03-04",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Myeloid Malignancies"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 54,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00213642",
          "briefTitle": "Tc-99m Renography and Cisplatin-induced Nephrotoxicity"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2001-07"
          },
          "completionDateStruct": {
            "date": "2004-08"
          }
        },
        "conditionsModule": {
          "conditions": ["Cancer", "Drug Toxicity", "Kidney Failure"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 20
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03589326",
          "briefTitle": "A Study of Ponatinib Versus Imatinib in Adults With Acute Lymphoblastic Leukemia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-10-04",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-07-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ALL)"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 245,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04415008",
          "briefTitle": "Efficacy of HAD Induction With Intensified Cytarabine in Newly-diagnosed CEBPA Double Mutated Acute Myeloid Leukemia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-06-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-06-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["CEBPA Double Mutation", "Acute Myeloid Leukemia"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 61,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "14 Years",
          "maximumAge": "55 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05716334",
          "briefTitle": "Biosimilars of Rituximab in ANCA-associated Vasculitis Compared to the Originator"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-06-15",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-09-15",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["ANCA-associated Vasculitis", "Granulomatosis With Polyangiitis", "Microscopic Polyangiitis"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 201,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01546038",
          "briefTitle": "A Study To Evaluate PF-04449913 With Chemotherapy In Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-06-27",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-03-04",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Acute Myeloid Leukemia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 255,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05387031",
          "briefTitle": "Efficacy of Ustekinumab Therapy in Patients With Symptomatic Stricturing Crohn's Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-08",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2027-08",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Crohn Disease", "Stricture; Bowel", "Intestinal Stricture"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 239,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06621199",
          "briefTitle": "Mitoxantrone Hydrochloride Liposome in Combination With Cytarabine and Venetoclax Regimen in Newly Diagnosed Elderly AML"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-07-08",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Acute Myeloid Leukemia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 42,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "60 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02772965",
          "briefTitle": "Low Dose Oral Methotrexate in Pediatric Crohn's Disease Patients Initiating Anti-Tumor Necrosis Factor (Anti-TNF) Therapy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-10"
          },
          "completionDateStruct": {
            "date": "2022-04-07",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Pediatric Crohn's Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 306,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "maximumAge": "20 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01743807",
          "briefTitle": "Phase I Study of GNKG168 in Acute Lymphoblastic Leukemia and Acute Myelogenous Leukemia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-03-26",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2014-07-28",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Relapsed Acute Lymphoblastic Leukemia", "Relapsed Acute Myelogenous Leukemia"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 4,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "1 Year",
          "maximumAge": "21 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06874257",
          "briefTitle": "Targeting Acute Myeloid Leukemia Immunosuppressive Microenvironment by combinedIDO1 Inhibition and PD-1 Blockade"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-04-17",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-10-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "AML (Acute Myelogenous Leukemia)"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 20,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02209792",
          "briefTitle": "Dose Finding Study of BIRB 796 BS in Patients With Moderate to Severe Crohn's Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2001-10"
          },
          "completionDateStruct": {}
        },
        "conditionsModule": {
          "conditions": "Crohn Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 284,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05166135",
          "briefTitle": "Latin American Real-world Study in Acute Leukemia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-12-10",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-11-15",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Acute Myeloid Leukemia", "Acute Lymphoid Leukemia"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 589,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "99 Years"
        }
      }
    ]
  }
}
